In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, ribociclib, in combination with the aromatase inhibitor letrozole, dramatically improved progression-free survival ...
Oct 11, 2016
0
1
Using biological markers—genetic characteristics that are associated with some patients with breast cancer—can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research ...
Oct 1, 2012
0
0
Researchers at the Broad Institute of MIT and Harvard, Koch Institute at MIT, Dana-Farber Cancer Institute, and Massachusetts General Hospital have developed an accurate, scalable approach for monitoring cancer DNA from blood ...
Nov 6, 2017
0
99
A team of researchers, including scientists from the Translational Genomics Research Institute (TGen), has reported that analyzing circulating tumor DNA (ctDNA) can track how a patient's cancer evolves and responds to treatment.
Nov 4, 2015
0
22
Among women with metastatic breast cancer, treatment with a drug that is biosimilar to the breast cancer drug trastuzumab resulted in an equivalent overall response rate at 24 weeks compared with trastuzumab, according to ...
Dec 1, 2016
0
4
Post-menopausal women with hormone receptor-positive metastatic breast cancer may have a new treatment option that could lengthen their lives, according to results of a study by the SWOG clinical trials network that were ...
Dec 7, 2011
0
0
QUT researchers are looking for Brisbane women who have been diagnosed with stage 2 (or above) breast cancer to take part in a study into the safety, feasibility and benefits of a regular exercise program.
Jan 11, 2017
0
1
Cancers can resist treatment by 'stealing' blood vessels from nearby tissues, a new study shows.
Apr 7, 2016
0
33
There is a group of metastatic breast cancers that has the HER2 gene amplified - the cells have many copies of it - which leads to enhanced activity of the product enzyme, a tyrosine kinase. HER2 has been established as a ...
Aug 1, 2017
0
45
For more than three decades, no new drug for the treatment of breast cancer has been presented. A group of researchers analyzing a marine sponge called Halichondrin okadai obtained a mesylate eribulin substance that had already ...
May 5, 2015
0
20
